GLPG-1205 Uses, Dosage, Side Effects and more
GLPG-1205 is under investigation in clinical trial NCT03725852 (A Clinical Study to Test How Effective and Safe GLPG1205 is for Patients With Idiopathic Pulmonary Fibrosis (IPF)).
| Attribute | Details |
|---|---|
| Trade Name | GLPG-1205 |
| Generic | GLPG-1205 |
| Type | |
| Formula | C22H22N2O4 |
| Weight | Average: 378.428 Monoisotopic: 378.157957196 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
